A

Acumen Pharmaceuticals
D

ABOS

1.91000
USD
-0.05
(-2.55%)
Post Trading
حجم التداول
1,242
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
115,695,242
الأخبار المقالات

العنوان: Acumen Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers.